Bruker Target Price

See Bruker's analyst price targets ($55) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$50.3

Average Target Price

$54.60

8.5% upside

5 analysts in the last 4 months

High: $70 | Low: $45

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-06-29	GuggenheimSubbu Nambi	$70	39.2% upside
2026-06-24	UBS	$60	19.3% upside
2026-05-08	Stifel NicolausDaniel Arias	$45	10.5% downside
2026-05-07	UBS	$45	10.5% downside
2026-05-07	BarclaysLuke Sergott	$53	5.4% upside
2026-02-13	Goldman SachsEvie Koslosky	$35	30.4% downside
2026-02-13	UBS	$49	2.6% downside
2026-02-13	BarclaysLuke Sergott	$50	0.6% downside
2026-02-12	Jefferies	$50	0.6% downside
2026-01-26	Guggenheim	$58	15.3% upside
2026-01-05	GuggenheimSubbu Nambi	$53	5.4% upside
2025-12-15	Wells FargoBrandon Couillard	$55	9.3% upside
2025-12-15	Barclays	$55	9.3% upside
2025-12-10	Wolfe Research	$60	19.3% upside
2025-12-09	Goldman Sachs	$40	20.5% downside
2025-11-20	Redburn Partners	$60	19.3% upside
2025-11-04	UBS	$43	14.5% downside
2025-11-04	Barclays	$45	10.5% downside
2025-10-02	Barclays	$40	20.5% downside
2025-08-05	Stifel NicolausDaniel Arias	$40	20.5% downside
2025-08-04	BarclaysLuke Sergott	$43	14.5% downside
2025-08-04	Jefferies	$60	19.3% upside
2024-12-19	GuggenheimSubbu Nambi	$72	43.1% upside
2024-09-23	CitigroupPatrick Donnelly	$80	59% upside
2024-08-27	Wells FargoBrandon Couillard	$78	55.1% upside
2024-05-20	Stifel NicolausDaniel Arias	$77	53.1% upside
2021-05-05	J.P. MorganTycho Peterson	$60	19.3% upside

Bruker (BRKR) FAQ

The latest target price for BRKR is $55. Investors often review this figure alongside Bruker's historical trend and sector peers before judging valuation or financial health.

Bruker trades near $50.3 while the consensus target sits at $55 (8.5% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting BRKR's target price ($55), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Bruker's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.